Development of Potent and Selective Inhibitors of ecto-5′-Nucleotidase Based on an Anthraquinone Scaffold-Reference-Cited by-同舟云学术

Development of Potent and Selective Inhibitors of ecto-5′-Nucleotidase Based on an Anthraquinone Scaffold

Published:2010-02-10 Issue:5 Volume:53 Page:2076-2086
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baqi Younis¹,Lee Sang-Yong¹,Iqbal Jamshed¹,Ripphausen Peter¹²,Lehr Anne¹,Scheiff Anja B.¹,Zimmermann Herbert³,Bajorath Jürgen²,Müller Christa E.¹

Affiliation:

1. PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, Pharmaceutical Sciences Bonn (PSB), University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany

2. Life Science Informatics, B-IT, LIMES−Chemical Biology and Medicinal Chemistry, University of Bonn, Dahlmannstrasse 2, 53113 Bonn, Germany

3. AK Neurochemie, Biozentrum der J.W. Goethe-Universität Frankfurt, Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm901851t

Reference78 articles.

1. Physiology and Pathophysiology of Purinergic Neurotransmission

2. Pathophysiology and Therapeutic Potential of Purinergic Signaling

3. P2-Pyrimidinergic Receptors and Their Ligands

4. P2 Receptors Activated by Uracil Nucleotides - An Update

5. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement—an in-depth review;Purinergic Signalling;2024-07-03

2. Small molecular CD73 inhibitors: Recent progress and future perspectives;European Journal of Medicinal Chemistry;2024-01

3. CD73 (5′-Ectonucleotidase);Metalloenzymes;2024

4. Anti-inflammatory potency of novel ecto-5′-nucleotidase/CD73 inhibitors in astrocyte culture model of neuroinflammation;European Journal of Pharmacology;2023-10

5. Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds;European Journal of Medicinal Chemistry;2023-10